{
    "xml": "<topic id=\"PHP1479\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/epoprostenol\" basename=\"epoprostenol\" title=\"EPOPROSTENOL\">\n<title>EPOPROSTENOL</title>\n<body>\n<data name=\"vtmid\">108593000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_935485240\" title=\"Prostaglandins (cardiovascular)\">Prostaglandins (cardiovascular)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\n<p outputclass=\"synonyms\">Prostacyclin</p>\n</body>\n<topic id=\"PHP64434\" outputclass=\"drugAction\" rev=\"1.14\" parent=\"/drugs/epoprostenol\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Epoprostenol (prostacyclin) is a prostaglandin and a potent vasodilator. It is also a powerful inhibitor of platelet aggregation.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64393\" outputclass=\"indicationsAndDose\" rev=\"1.17\" parent=\"/drugs/epoprostenol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Inhibition of platelet aggregation during renal dialysis when heparins are unsuitable or contra-indicated</p>\n<p outputclass=\"therapeuticIndication\">Treatment of primary pulmonary hypertension resistant to other treatments, usually with oral anti-coagulation (initiated by a specialist)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By continuous intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"pharmacokinetics\">\n<title>Pharmacokinetics</title>\n<p>Short half-life of approximately 3 minutes, therefore it must be administered by continuous intravenous infusion.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64446\" outputclass=\"contraindications\" rev=\"1.5\" parent=\"/drugs/epoprostenol\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Severe left ventricular dysfunction</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64465\" outputclass=\"cautions\" rev=\"1.20\" parent=\"/drugs/epoprostenol\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Avoid abrupt withdrawal when used for primary pulmonary hypertension (risk of rebound pulmonary hypertension)</ph>; <ph outputclass=\"caution\">extreme caution in coronary artery disease</ph>; <ph outputclass=\"caution\">haemorrhagic diathesis</ph>; <ph outputclass=\"caution\">pulmonary veno-occlusive disease</ph>; <ph outputclass=\"caution\">reconstituted solution highly alkaline&#8212;avoid extravasation (irritant to tissues)</ph>; <ph outputclass=\"caution\">risk of pulmonary oedema (dose titration for pulmonary hypertension should be in hospital)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64383\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/epoprostenol\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Caution with concomitant use of drugs that increase risk of bleeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64346\" outputclass=\"sideEffects\" rev=\"1.31\" parent=\"/drugs/epoprostenol\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">anxiety</ph>; <ph outputclass=\"sideEffect\">arthralgia</ph>; <ph outputclass=\"sideEffect\">bleeding</ph>; <ph outputclass=\"sideEffect\">bradycardia</ph>; <ph outputclass=\"sideEffect\">chest pain</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">jaw pain</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">sepsis</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dry mouth</ph>; <ph outputclass=\"sideEffect\">sweating</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Agitation</ph>; <ph outputclass=\"sideEffect\">hyperthyroidism</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">pallor</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hyperglycaemia</ph>; <ph outputclass=\"sideEffect\">pulmonary oedema (avoid chronic use if occurs during dose titration)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64377\" outputclass=\"pregnancy\" parent=\"/drugs/epoprostenol\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64476\" outputclass=\"breastFeeding\" parent=\"/drugs/epoprostenol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64311\" outputclass=\"monitoringRequirements\" parent=\"/drugs/epoprostenol\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Anticoagulant monitoring required when given with anticoagulants.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64328\" outputclass=\"treatmentCessation\" rev=\"1.9\" parent=\"/drugs/epoprostenol\">\n<title>Treatment cessation</title>\n<body>\n<section>\n<sectiondiv>\n<p>Avoid abrupt withdrawal when used for primary pulmonary hypertension (risk of rebound pulmonary hypertension).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64507\" outputclass=\"directionsForAdministration\" rev=\"1.37\" parent=\"/drugs/epoprostenol\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (<i>Flolan</i>\n<tm tmtype=\"reg\"/>), give continuously in Sodium chloride 0.9%; reconstitute using the filter and solvent (glycine buffer diluent) provided to make a concentrate; may be diluted further (consult product literature); for <i>pulmonary hypertension </i> dilute further with glycine buffer diluent only and administer via a central venous catheter (can give via peripheral vein until central venous access established).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (<i>Flolan</i>\n<tm tmtype=\"reg\"/>), give continuously in Sodium chloride 0.9%; reconstitute using the filter and solvent (glycine buffer diluent) provided to make a concentrate; may be diluted further (consult product literature); for <i>renal dialysis</i> may be diluted further with sodium chloride 0.9%; protect infusion from light.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (<i>Veletri</i>\n<tm tmtype=\"reg\"/>), give continuously in Sodium chloride 0.9%; reconstitute each vial with 5&#8239;mL sodium chloride 0.9% then dilute to required concentration with sodium chloride 0.9% (consult product literature); administer through an in-line 0.22&#8239;micron filter; for <i>pulmonary hypertension</i>, administer via a central venous catheter (can give via peripheral vein until central venous access established); protect infusion from direct sunlight.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1479-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/epoprostenol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77375\" title=\"Powder for solution for infusion\" namespace=\"/drugs/epoprostenol/powder-for-solution-for-infusion\">Powder for solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77368\" title=\"Powder and solvent for solution for infusion\" namespace=\"/drugs/epoprostenol/powder-and-solvent-for-solution-for-infusion\">Powder and solvent for solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78159\" namespace=\"/treatment-summaries/antihypertensive-drugs\" title=\"Antihypertensive drugs\" count=\"1\" rel=\"backlink\">Antihypertensive drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78186\" namespace=\"/treatment-summaries/antiplatelet-drugs\" title=\"Antiplatelet drugs\" count=\"1\" rel=\"backlink\">Antiplatelet drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77375\" namespace=\"/drugs/epoprostenol/powder-for-solution-for-infusion\" title=\"Powder for solution for infusion\" count=\"1\" rel=\"link\">Powder for solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77368\" namespace=\"/drugs/epoprostenol/powder-and-solvent-for-solution-for-infusion\" title=\"Powder and solvent for solution for infusion\" count=\"1\" rel=\"link\">Powder and solvent for solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP1479",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/epoprostenol",
    "basename": "epoprostenol",
    "title": "EPOPROSTENOL",
    "vtmid": "108593000",
    "drugClassification": [
        "Prostaglandins (cardiovascular)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Prostacyclin"
    ],
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Epoprostenol (prostacyclin) is a prostaglandin and a potent vasodilator. It is also a powerful inhibitor of platelet aggregation.",
                "html": "<p>Epoprostenol (prostacyclin) is a prostaglandin and a potent vasodilator. It is also a powerful inhibitor of platelet aggregation.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Inhibition of platelet aggregation during renal dialysis when heparins are unsuitable or contra-indicated",
                        "html": "Inhibition of platelet aggregation during renal dialysis when heparins are unsuitable or contra-indicated"
                    },
                    {
                        "textContent": "Treatment of primary pulmonary hypertension resistant to other treatments, usually with oral anti-coagulation (initiated by a specialist)",
                        "html": "Treatment of primary pulmonary hypertension resistant to other treatments, usually with oral anti-coagulation (initiated by a specialist)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "continuous intravenous infusion"
                    ],
                    "textContent": "By continuous intravenous infusion",
                    "html": "By continuous intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>"
                    }
                ]
            }
        ],
        "pharmacokinetics": [
            {
                "type": "pharmacokinetics",
                "title": "Pharmacokinetics",
                "textContent": "Short half-life of approximately 3 minutes, therefore it must be administered by continuous intravenous infusion.",
                "html": "<p>Short half-life of approximately 3 minutes, therefore it must be administered by continuous intravenous infusion.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Severe left ventricular dysfunction",
                "html": "Severe left ventricular dysfunction"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Avoid abrupt withdrawal when used for primary pulmonary hypertension (risk of rebound pulmonary hypertension)",
                "html": "Avoid abrupt withdrawal when used for primary pulmonary hypertension (risk of rebound pulmonary hypertension)"
            },
            {
                "type": "cautions",
                "textContent": "extreme caution in coronary artery disease",
                "html": "extreme caution in coronary artery disease"
            },
            {
                "type": "cautions",
                "textContent": "haemorrhagic diathesis",
                "html": "haemorrhagic diathesis"
            },
            {
                "type": "cautions",
                "textContent": "pulmonary veno-occlusive disease",
                "html": "pulmonary veno-occlusive disease"
            },
            {
                "type": "cautions",
                "textContent": "reconstituted solution highly alkaline&#8212;avoid extravasation (irritant to tissues)",
                "html": "reconstituted solution highly alkaline&#8212;avoid extravasation (irritant to tissues)"
            },
            {
                "type": "cautions",
                "textContent": "risk of pulmonary oedema (dose titration for pulmonary hypertension should be in hospital)",
                "html": "risk of pulmonary oedema (dose titration for pulmonary hypertension should be in hospital)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Caution with concomitant use of drugs that increase risk of bleeding.",
                "html": "<p>Caution with concomitant use of drugs that increase risk of bleeding.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "anxiety",
                        "html": "anxiety",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "arthralgia",
                        "html": "arthralgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "bleeding",
                        "html": "bleeding",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "bradycardia",
                        "html": "bradycardia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "chest pain",
                        "html": "chest pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "jaw pain",
                        "html": "jaw pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "sepsis",
                        "html": "sepsis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tachycardia",
                        "html": "tachycardia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Dry mouth",
                        "html": "Dry mouth",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "sweating",
                        "html": "sweating",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Agitation",
                        "html": "Agitation",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hyperthyroidism",
                        "html": "hyperthyroidism",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "pallor",
                        "html": "pallor",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Hyperglycaemia",
                        "html": "Hyperglycaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pulmonary oedema (avoid chronic use if occurs during dose titration)",
                        "html": "pulmonary oedema (avoid chronic use if occurs during dose titration)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use if potential benefit outweighs risk.",
                "html": "<p>Use if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Anticoagulant monitoring required when given with anticoagulants.",
                "html": "<p>Anticoagulant monitoring required when given with anticoagulants.</p>"
            }
        ]
    },
    "treatmentCessation": {
        "treatmentCessation": [
            {
                "type": "treatmentCessation",
                "textContent": "Avoid abrupt withdrawal when used for primary pulmonary hypertension (risk of rebound pulmonary hypertension).",
                "html": "<p>Avoid abrupt withdrawal when used for primary pulmonary hypertension (risk of rebound pulmonary hypertension).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Flolan ), give continuously in Sodium chloride 0.9%; reconstitute using the filter and solvent (glycine buffer diluent) provided to make a concentrate; may be diluted further (consult product literature); for pulmonary hypertension dilute further with glycine buffer diluent only and administer via a central venous catheter (can give via peripheral vein until central venous access established).",
                "html": "<p>For <i>intravenous infusion</i> (<i>Flolan</i>\n<tm tmtype=\"reg\"/>), give continuously in Sodium chloride 0.9%; reconstitute using the filter and solvent (glycine buffer diluent) provided to make a concentrate; may be diluted further (consult product literature); for <i>pulmonary hypertension </i> dilute further with glycine buffer diluent only and administer via a central venous catheter (can give via peripheral vein until central venous access established).</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Flolan ), give continuously in Sodium chloride 0.9%; reconstitute using the filter and solvent (glycine buffer diluent) provided to make a concentrate; may be diluted further (consult product literature); for renal dialysis may be diluted further with sodium chloride 0.9%; protect infusion from light.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Flolan</i>\n<tm tmtype=\"reg\"/>), give continuously in Sodium chloride 0.9%; reconstitute using the filter and solvent (glycine buffer diluent) provided to make a concentrate; may be diluted further (consult product literature); for <i>renal dialysis</i> may be diluted further with sodium chloride 0.9%; protect infusion from light.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Veletri ), give continuously in Sodium chloride 0.9%; reconstitute each vial with 5 mL sodium chloride 0.9% then dilute to required concentration with sodium chloride 0.9% (consult product literature); administer through an in-line 0.22 micron filter; for pulmonary hypertension, administer via a central venous catheter (can give via peripheral vein until central venous access established); protect infusion from direct sunlight.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Veletri</i>\n<tm tmtype=\"reg\"/>), give continuously in Sodium chloride 0.9%; reconstitute each vial with 5&#8239;mL sodium chloride 0.9% then dilute to required concentration with sodium chloride 0.9% (consult product literature); administer through an in-line 0.22&#8239;micron filter; for <i>pulmonary hypertension</i>, administer via a central venous catheter (can give via peripheral vein until central venous access established); protect infusion from direct sunlight.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77375",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77368",
                "label": "Powder and solvent for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78159",
                "label": "Antihypertensive drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78186",
                "label": "Antiplatelet drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77375",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77368",
                "label": "Powder and solvent for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}